Log In
Print
BCIQ
Print
Print this Print this
 

N8-GP (NN7088)

  Manage Alerts
Collapse Summary General Information
Company Novo Nordisk A/S
DescriptionLong-acting, glycopegylated formulation of turoctocog alfa, a recombinant Factor Vlll (rFVIII)
Molecular Target Factor VIII
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase III
Standard IndicationHemophilia
Indication DetailsTreat hemophilia A
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today